Source: Biospectrum Asia

Hamatogenix: First central oncology laboratory for clinical trials opens in Malaysia

Hematogenix marks the opening of the first central laboratory in clinical research in Malaysia

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Hytham Al-Masri's photo - CEO of Hamatogenix

CEO

Hytham Al-Masri

CEO Approval Rating

- -/100

Read more